STOCK TITAN
  1. Home
  2. Sec-filings
  3. MDT
  4. [Form 4] Medtronic plc Insider Trading Activity

Medtronic (NYSE: MDT) director receives 1,444-share restricted stock award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Groetelaars John P reported acquisition or exercise transactions in this Form 4 filing.

Medtronic plc director John P. Groetelaars received a stock award rather than buying shares on the market. He was granted 1,444 ordinary shares on a Form 4 report, at a stated price of $0.00 per share, as compensation.

The award represents restricted stock units that vest on the one-year anniversary of the grant date, so he must remain eligible through that period to receive the shares. Following this grant, his directly held position reported in this filing is 1,444 ordinary shares, reflecting a small, routine equity award for a board member.

Positive

  • None.

Negative

  • None.
Insider Groetelaars John P
Role null
Type Security Shares Price Value
Grant/Award Ordinary Shares 1,444 $0.00 --
Holdings After Transaction: Ordinary Shares — 1,444 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares granted 1,444 shares Grant of Medtronic ordinary shares reported on Form 4
Grant price per share $0.00 per share Compensation-related stock award, not an open-market purchase
Shares held after grant 1,444 shares Direct ownership position for John P. Groetelaars following the award
restricted stock units financial
"Represents an award of restricted stock units that vest on the one-year anniversary"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
Ordinary Shares financial
"security_title: "Ordinary Shares""
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Groetelaars John P
(Last)(First)(Middle)
C/O MEDTRONIC
710 MEDTRONIC PARKWAY
(Street)
MINNEAPOLIS MINNESOTA 55432
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/27/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares04/27/2026A1,444(1)A$01,444D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents an award of restricted stock units that vest on the one-year anniversary of the award date.
Remarks:
/s/ Patricia Walesiewicz, attorney-in-fact04/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does the latest Form 4 for Medtronic (MDT) show for John P. Groetelaars?

The Form 4 shows director John P. Groetelaars received an equity award of 1,444 Medtronic ordinary shares. These were granted as compensation, not bought in the open market, and are structured as restricted stock units that vest after one year.

How many Medtronic (MDT) shares were granted to director John P. Groetelaars?

John P. Groetelaars was granted 1,444 Medtronic ordinary shares. The Form 4 reports a transaction price of $0.00 per share, indicating a compensation-related grant rather than a cash purchase, and shows his direct holdings as 1,444 shares after the award.

What is the vesting schedule for John P. Groetelaars’ Medtronic (MDT) restricted stock units?

The award consists of restricted stock units that vest on the one-year anniversary of the award date. This means Groetelaars must remain eligible for a full year before the units convert into Medtronic ordinary shares that he fully owns.

Was John P. Groetelaars’ Medtronic (MDT) Form 4 transaction an open-market purchase?

No. The Form 4 reports a grant coded as a "Grant, award, or other acquisition" with a $0.00 price per share. This indicates a compensation-related stock award, not an open-market purchase where the director paid cash for Medtronic shares.

How did the equity award affect John P. Groetelaars’ Medtronic (MDT) share ownership?

Following the grant, John P. Groetelaars is reported as directly holding 1,444 Medtronic ordinary shares. The filing does not list other holdings, so this equity award establishes his current reported direct ownership position from this specific Form 4.